DCGI allowed emergency use of this medicine of Zydus Cadila for the treatment of Corona


Posted on 23rd Apr 2021 06:50 pm by rohit kumar

Corona's uncontrollable pace has created a serious crisis in the country. All the efforts taken by the government are inadequate and the patients of Corona are continuously dying. Meanwhile, the Drugs Controller General of India (DCGI) has approved the emergency use of 'Virafin' of Ahmedabad-based drugmaker Zydus Cadila.

 

 

Zydus Cadila stated that Pegylated Interferon alpha-2b, 'Virafin' is greatly helped by emergency use in adults with Covid-19 infection. Zydus Cadila said that 'Virafin' will be provided to hospitals.

 

 

Earlier, Zydus Cadila had sought approval from the Drug Controller General of India for the treatment of Covid-19. The company had said that the drug Pegylated Interferon Alpha 2b or PegiHep has proved to be effective 91.15 percent. The initial third-phase human trial yielded promising results from the drug. Interim results indicated that timely delivery of the drug may help patients recover more quickly and avoid the complication seen in the advanced stages of the disease.

 

 

Pegylated Interferon Alpha 2b or PegiHep is an approved drug in India and has been re-formulated for the treatment of Covid-19. Preliminary results of Phase III human testing showed that drug use cured 91.15 percent of Covid-19 patients within 7 days and their positive corona test report was negative in the RT-PCR test.

 

 

The company claims that Pegylated Interferon Alpha 2b or PegiHep is a single-dose drug. With single-dose medicine, treatment will be less cumbersome and more economical for the patients. According to the company, during the test, drug-dependent patients also had less need for oxygen support. This makes it clear that the drug can control shortness of breath, which is a major challenge in the treatment of Covid-19.

 

 

"We are excited by the results of the Phase III trial of Pegylated Interferon Alpha 2b which confirmed the possibility of reducing the impact of the virus on the timely use of the disease," said Shravil Patel of Cadila Healthcare. In December 2020, the company was permitted the drug regulator to start Phase III human trials on Covid-19 patients.

2 Like 0 Dislike
Previous news Next news
Other news

PM Modi in America: How is the security of the Prime Minister of India ensured abroad, who takes the responsibility

Prime Minister Narendra Modi has reached America. Here he is to meet US President Donald Trump. P

Pieces of bullet were trapped in Imran Khan's leg: Former PM's operation lasted for one and a half hours, and bone was cut

The condition of the former Prime Minister of Pakistan is stable now. His operation lasted an hou

RSS: Will RSS be able to achieve this impossible goal? Sangh's big plan regarding UP-Bihar

Keeping in mind the next Lok Sabha elections, the opposition has also started throwing its dice.

Xi Jinping: Chinese President Xi Jinping met the King and Crown Prince of Saudi Arabia, and several agreements were signed

Chinese President Xi Jinping met with King Salman and the Crown Prince of Saudi Arabia on Thursda

SRH vs GT Playing 11: Hyderabad eyes a place in the playoffs, will face Gujarat today, see playing 11

Despite not being able to maintain consistency in performance, Sunrisers Hyderabad need

Redmi's much-awaited phone launch, know what is special in its features and how much is the price?

Redmi K50i 5G Phone On Amazon: For the past several days, the teaser of a new Redmi phone was run

IPL 2021, RR vs MI: Rajasthan and Mumbai will have tough competition, these players can change the course of the match

In the IPL (IPL 2021) on Tuesday, there will be a match between such teams of the season, who wil

India Lockdown Updates: Lockdown extended in these big states of the country, know where the tightening ban took place

The second wave of Corona in the country has caused outrage. Most states of the country have come

Samsung Galaxy A13 and A23 launched in India, Galaxy M33 5G will knock on this day

Samsung has launched 2 new cheap smartphones Samsung Galaxy A13 And Galaxy A23 4G in India. Both

SC to hear Krishna Janmabhoomi-Shahi Idgah dispute today, Shahi Masjid Idgah Management Trust Committee has filed a petition.

The Supreme Court will hear many important cases on Tuesday including the bulldozer campaign, Sri

Sign up to write
Sign up now if you have flare of writing..
Login   |   Register
Follow Us
Indyaspeak @ Facebook Indyaspeak @ Twitter Indyaspeak @ Pinterest RSS



Play Free Quiz and Win Cash